Sponsor pipeline

Vima Therapeutics clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT07304089	A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With…	Dystonia	Recruiting	2026-09-15
NCT07804615	A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With…	PARKINSON DISEASE (Disorder)	Recruiting	2026-09-11
Not specified
NCT07111663	An Observational Study of Individuals With Isolated Dystonia	Isolated/Primary Dystonia That Affects More Than One Region of the Body	Active, Not Recruiting	2026-09-21

Get alerts when Vima Therapeutics's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.